Collaborative care for sick-listed workers with major depressive disorder: a randomised controlled trial from the Netherlands Depression Initiative aimed at return to work and depressive symptoms

2012 ◽  
Vol 70 (4) ◽  
pp. 223-230 ◽  
Author(s):  
Moniek C Vlasveld ◽  
Christina M van der Feltz-Cornelis ◽  
Herman J Adèr ◽  
Johannes R Anema ◽  
Rob Hoedeman ◽  
...  
1997 ◽  
Vol 171 (2) ◽  
pp. 131-134 ◽  
Author(s):  
Christine Scott ◽  
Mary Jane Tacchi ◽  
Roger Jones ◽  
Jan Scott

BackgroundThe consensus statement on the treatment of depression (Paykel & Priest, 1992) advocates the use of cognitive therapy techniques as an adjunct to medication.MethodThis paper describes a randomised controlled trial of brief cognitive therapy (BCT) plus ‘treatment as usual’ versus treatment as usual in the management of 48 patients with major depressive disorder presenting in primary care.ResultsAt the end of the acute phase, significantly more subjects (P < 0.05) met recovery criteria in the intervention group (n=15) compared with the control group (n=8). When initial neuroticism scores were controlled for, reductions in Beck Depression Inventory and Hamilton Rating Scale for Depression scores favoured the BCT group throughout the 12 months of follow-up.ConclusionsBCT may be beneficial, but given the time constraints, therapists need to be more rather than less skilled in cognitive therapy. This, plus methodological limitations, leads us to advise caution before applying this approach more widely in primary care.


2012 ◽  
Vol 200 (6) ◽  
pp. 510-511 ◽  
Author(s):  
M. C. Vlasveld ◽  
C. M. van der Feltz-Cornelis ◽  
H. J. Adèr ◽  
J. R. Anema ◽  
R. Hoedeman ◽  
...  

SummaryRandomised controlled trial to evaluate the effectiveness of collaborative care in a Dutch occupational healthcare setting: 126 workers on sick leave with major depressive disorder were randomised to usual care (n = 61) or collaborative care (n = 65). After 3 months, collaborative care was more effective on the primary outcome measure of treatment response (i.e. reduction in symptoms of ≥50%) on the Patient Health Questionnaire-9 (PHQ-9). However, the groups did not differ on the PHQ-9 as a continuous outcome measure. Implications of these results are discussed.


Sign in / Sign up

Export Citation Format

Share Document